Pharmacodynamics<unk>  is a non-selective agonist of the melanocortin receptors, MC1 through MC5 (with the exception of MC2, the receptor of ), but acting primarily as an MC3 and MC4 receptor agonist. Pharmacokinetics The bioavailability of<unk>  with subcutaneous injection is about 100%. Following a subcutaneous injection of<unk> , maximal levels occur after about one hour, with a range of 0.5 to 1.0 hours. The plasma protein binding of<unk>  is 21%.<unk>  is metabolized via hydrolysis of its peptide bonds. The elimination half-life of<unk>  is 2.7 hours, with a range of 1.9 to 4.0 hours.<unk>  is excreted 64.8% in urine and 22.8% in feces.
Bremelanotide
Rivastigmine
Carbidopa/levodopa
Tianeptine
Donepezil
Glysobuzole
Glybuzole
Fluorodopa